Related Experiment Video
Updated: Oct 25, 2025

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Human APOBEC3 Variations and Viral Infection
Shiva Sadeghpour1, Saeideh Khodaee2, Mostafa Rahnama3
1Department of Biological Science, University of California Irvine, Irvine, CA 92697, USA.
Abstract:
Human APOBEC3 (apolipoprotein B mRNA-editing catalytic polypeptide-like 3) enzymes are capable of inhibiting a wide range of endogenous and exogenous viruses using deaminase and deaminase-independent mechanisms. These enzymes are essential components of our innate immune system, as evidenced by (a) their strong positive selection and expansion in primates, (b) the evolution of viral counter-defense mechanisms, such as proteasomal degradation mediated by HIV Vif, and (c) hypermutation and inactivation of a large number of integrated HIV-1 proviruses. Numerous APOBEC3 single nucleotide polymorphisms, haplotypes, and splice variants have been identified in humans. Several of these variants have been reported to be associated with differential antiviral immunity. This review focuses on the current knowledge in the field about these natural variations and their roles in infectious diseases.
Insights
Human APOBEC3 enzymes are key innate immune components that fight viruses through various mechanisms. Natural variations in these enzymes influence antiviral immunity and infectious disease outcomes.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Human apolipoprotein B mRNA-editing catalytic polypeptide-like 3 (APOBEC3) enzymes are crucial for innate immunity.
- These enzymes inhibit diverse viruses via deaminase-dependent and -independent pathways.
- Evidence includes primate-specific expansion, viral counter-defenses (e.g., HIV Vif), and HIV-1 proviral inactivation.
Purpose of the Study:
- To review current knowledge on natural variations within human APOBEC3 enzymes.
- To explore the impact of these genetic variations on antiviral immunity.
- To understand the role of APOBEC3 variants in infectious diseases.
Main Methods:
- Literature review of studies on human APOBEC3 genetic variations.
- Analysis of identified single nucleotide polymorphisms, haplotypes, and splice variants.
- Examination of reported associations between APOBEC3 variants and antiviral responses.
Main Results:
- Numerous APOBEC3 genetic variants exist in the human population.
- Several variants are linked to differential efficacy in antiviral immunity.
- These variations contribute to the complex interplay between host and virus.
Conclusions:
- Natural variations in human APOBEC3 enzymes significantly modulate antiviral immunity.
- Understanding these variants is critical for comprehending infectious disease dynamics.
- Further research into APOBEC3 polymorphisms can inform therapeutic strategies.
Related Concept Videos
Viral Mutations
Viral Recombination
Retroviruses
Leaky Scanning
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

